Sargent Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.18M | Buy |
41,649
+3,028
| +8% | +$594K | 1.11% | 23 |
|
|
2025
Q1 | $8.09M | Buy |
38,621
+2,335
| +6% | +$489K | 1.29% | 21 |
|
|
2024
Q4 | $6.41M | Sell |
36,286
-10,876
| -23% | -$1.92M | 1.05% | 24 |
|
|
2024
Q3 | $9.31M | Buy |
47,162
+1,470
| +3% | +$290K | 1.67% | 17 |
|
|
2024
Q2 | $7.84M | Buy |
45,692
+41,296
| +939% | +$7.08M | 1.6% | 17 |
|
|
2024
Q1 | $801K | Sell |
4,396
-4,173
| -49% | -$760K | 0.18% | 94 |
|
|
2023
Q4 | $1.33M | Buy |
8,569
+625
| +8% | +$96.9K | 0.29% | 69 |
|
|
2023
Q3 | $1.18M | Sell |
7,944
-508
| -6% | -$75.7K | 0.29% | 71 |
|
|
2023
Q2 | $1.14M | Sell |
8,452
-460
| -5% | -$62K | 0.28% | 72 |
|
|
2023
Q1 | $1.43M | Buy |
8,912
+489
| +6% | +$78.4K | 0.38% | 60 |
|
|
2022
Q4 | $1.36M | Sell |
8,423
-25
| -0.3% | -$4.04K | 0.42% | 59 |
|
|
2022
Q3 | $1.19M | Buy |
8,448
+660
| +8% | +$92.6K | 0.37% | 63 |
|
|
2022
Q2 | $1.19M | Buy |
7,788
+390
| +5% | +$59.7K | 0.37% | 60 |
|
|
2022
Q1 | $1.2M | Sell |
7,398
-50
| -0.7% | -$8.1K | 0.3% | 60 |
|
|
2021
Q4 | $1.01M | Buy |
7,448
+200
| +3% | +$27.1K | 0.23% | 75 |
|
|
2021
Q3 | $782K | Buy |
7,248
+171
| +2% | +$18.5K | 0.19% | 88 |
|
|
2021
Q2 | $797K | Buy |
7,077
+875
| +14% | +$98.5K | 0.19% | 85 |
|
|
2021
Q1 | $671K | Buy |
6,202
+2,700
| +77% | +$292K | 0.18% | 98 |
|
|
2020
Q4 | $375K | Buy |
3,502
+900
| +35% | +$96.4K | 0.12% | 128 |
|
|
2020
Q3 | $228K | Buy |
2,602
+237
| +10% | +$20.8K | 0.08% | 146 |
|
|
2020
Q2 | $234K | Buy |
+2,365
| New | +$234K | 0.09% | 131 |
|
|
2019
Q2 | – | Sell |
-2,675
| Closed | -$216K | – | 143 |
|
|
2019
Q1 | $216K | Sell |
2,675
-510
| -16% | -$41.2K | 0.1% | 126 |
|
|
2018
Q4 | $294K | Buy |
+3,185
| New | +$294K | 0.18% | 94 |
|